Quadrature Capital’s Sana Biotechnology SANA Stock Holding History

Quadrature Capital’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Buy	77,056 +63,052	+450%	+$203K	﹤0.01%	1247
2026 Q1	$40.3K	Buy	+14,004	New	+$55.2K	﹤0.01%	1291
2025 Q4	–	Sell	-61,232	Closed	-$217K	–	1601
2025 Q3	$217K	Buy	+61,232	New	+$221K	﹤0.01%	761
2025 Q2	–	Sell	-74,202	Closed	-$125K	–	1428
2025 Q1	$125K	Buy	+74,202	New	+$207K	﹤0.01%	913

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Quadrature Capital's SANA Position: Q2 2026 in Review

Quadrature Capital increased its Sana Biotechnology (SANA) stake by 450% in Q2 2026, buying an estimated $203K and bringing the position to 77,056 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Quadrature Capital first reported a position in SANA in Q1 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Quadrature Capital held 77,056 shares of Sana Biotechnology worth $269K as of Q2 2026.
Quadrature Capital bought 63,052 Sana Biotechnology shares in Q2 2026, an estimated $203K.
Sana Biotechnology made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1247 holding.
Quadrature Capital first reported a position in Sana Biotechnology in Q1 2025 and has held it in 4 quarters since.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.